Clinical Trial Update: Non-comparative Study of IFX-1 Alone or IFX-1+Pembrolizumab in Patients With Locally Advanced or Metastatic cSCC. [Phase 2]

View source ↗

Summary

Phase 2 non-comparative trial evaluating IFX-1 alone or with pembrolizumab in locally advanced or metastatic cutaneous squamous cell carcinoma; the study was te…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Squamous Cell Carcinoma

Drugs mentioned

• IFX-1 (vilobelimab)
• KEYTRUDA (PEMBROLIZUMAB)

Snippet

Sponsor: InflaRx GmbH | Conditions: SCC - Squamous Cell Carcinoma of Skin | Phase 2 | Status: TERMINATED | Results posted: 2025-02-11